Cart
sales@molnova.com
Cyclocytidine hydrochloride
CAS No. 10212-25-6
Cyclocytidine hydrochloride( —— )
Catalog No. M10101 CAS No. 10212-25-6
Cyclocytidine is the prodrug of cytarabine, which is a pyrimidine nucleoside analog that inhibits the DNA synthesis and used mainly in the treatment of leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 33 | In Stock |
|
| 200MG | 43 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyclocytidine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclocytidine is the prodrug of cytarabine, which is a pyrimidine nucleoside analog that inhibits the DNA synthesis and used mainly in the treatment of leukemia.
-
DescriptionCyclocytidine is the prodrug of cytarabine, which is a pyrimidine nucleoside analog that inhibits the DNA synthesis and used mainly in the treatment of leukemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number10212-25-6
-
Formula Weight261.66
-
Molecular FormulaC9H12ClN3O4
-
Purity>98% (HPLC)
-
SolubilityWater: 44 mg/mL warmed (168.15 mM); DMSO: 52 mg/mL warmed (198.73 mM)
-
SMILESC1=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)OC2=NC1=N.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kirsch LE, et al. J Pharm Sci, 1984, 73(7), 896-902.
molnova catalog
related products
-
6-Mercaptopurine mon...
ercaptopurine is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.
-
JH-RE-06
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.
-
TMPyP4 tosylate
TMPyP4 tosylate is a quadruplex-specific ligand and is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines.
